Skip to main content

UCB Pharma to Use Entelos PhysioLab for Rheumatoid Arthritis Research

NEW YORK (GenomeWeb News) - Entelos said today that UCB Pharma will use its PhysioLab biosimulation platform for rheumatoid arthritis research.
 
The Rheumatoid Arthritis PhysioLab is a predictive computer model that simulates arthritic patients and drug effects.
 
The company said that researchers use the system to select targets and compounds, find the best doses for patients, and support clinical trial design.
 
Financial terms of the agreement were not disclosed.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.